期刊文献+

胃癌组织中S-100蛋白表达的临床意义 被引量:2

The clinical significance of S-100 protein′s expresson in gastric carcinoma
暂未订购
导出
摘要 目的探讨胃癌组织中S-100蛋白的表达在胃癌发生、发展、预后以及治疗中的临床意义。方法应用免疫组织化学方法对51例胃癌标本、17例正常胃黏膜标本中的S-100阳性细胞(S-100+DC)进行检测。结果 S-100+DC在胃癌组中的表达显著高于正常胃黏膜组(P<0.05)。S-100+DC的表达率与分化程度、淋巴结转移、远处转移密切相关(P<0.05),而与肿瘤的大小、浸润深度无关(P>0.05)。结论胃癌微环境中S-100+DC的表达与胃癌的临床病理参数密切相关。S-l00蛋白的表达水平可评价DC在肿瘤组织中的浸润程度,以此可观察肿瘤患者机体的免疫状态,估计肿瘤的转移、预后等情况。 Purpose To study the clinical significance of the expression of S-100 protein in the occur- rence,development,prognosis and treatment of the gastric carcinoma. Methods S-100 positive cells (S- 100 + DC) were detected in 51 specimens of gastric carcinoma and 17 specimens of normal gastric muco- sa using immunohistochemical method. Results The expression of S-100 + DC in gastric carcinoma was obviously higher than that in normal gastric mucosa(P 〈 0.05 ). The positive rates of S-100 + DC were correlated with the degree of differentiation,lymph node metastasis and distant metastasis(P 〈 0.05 ), and irrelevant with the tumor size and depth of invasion(P 〉 0.05 ). Conclusion The expression of S-100 + DC in the micro environment of gastric carcinoma was closely correlated with the clinical pathological pa- rameters. The expression level of S-100 protein can estimate the infiltration of DC in gastric carcinoma ti- ussue. By force of that we can observe the immune state of tumor patients and estimate the situation of tumor's metastasis and prognosis.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2012年第5期643-645,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 S-100蛋白 树突状细胞 免疫组织化学 胃癌 S-100 protein dendritic cells immunohistochemistry gastric carcinoma
  • 相关文献

参考文献8

二级参考文献90

共引文献21

同被引文献18

  • 1Yutaka Oomura.Expression of nesfatin-1/NUCB2 in rodent digestive system[J].World Journal of Gastroenterology,2010,16(14):1735-1741. 被引量:7
  • 2时兰春,王缚鲲,王仁杰,王江雁.胃液pH与幽门螺杆菌感染及抗-HpIgA含量的分析[J].中国人兽共患病学报,2006,22(3):240-242. 被引量:1
  • 3李丽秋,孙玉清,马淑霞,吕密凯,王秀国,李鹰.老年人萎缩性胃炎和胃癌与胃液pH及微生态环境改变的关系探讨[J].中国微生态学杂志,1997,9(1):23-24. 被引量:4
  • 4Suleyman Aydin,Ersel Dag,Yusuf Ozkan,Ozgur Arslan,Guray Koc,Semai Bek,Serkan Kirbas,Tayfun Kasikci,Dilek Abasli,Zeki Gokcil,Zeki Odabasi,Zekiye Catak.Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients[J].Peptides.2011(6)
  • 5叶任高.内科学[M].5版.人民卫生出版社,2001:807.
  • 6Oh- I S, Shimizu H, Satoh T, et al. Identification of nesfa- tin-1 as a satiety molecule in the hypothalamus[ J]. Nature,2006,443(7112) :709-712.
  • 7Zhang AQ, Li XL, Jiang CY, et al. Expression of nesfatin- 1/NUCB2 in rodent digestive system[ J]. World J Gastroen- terol,2010,16(14) : 1735-1741.
  • 8Kojima M, Hosoda H, Date Y, et al.Ghrelin is a growth-hor- mone-releasing acylated peptide from stomach [ J ]. Nature, 1999,402(6762) :656-660.
  • 9Xia ZF, Fritze DM, Li JY, et al. Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats[ J]. Am J Physiol Gastrointest Liver Physiol, 2012, 303 (5): G570-G577.
  • 10Aydin S, Dag E, Ozkan Y. Time-dependent changes in the serum levels Of prolactin, Nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients [ J ]. Peptides, 2011, 32(6) : 1276-1280.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部